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Twenty-three years ago, numb was identified as a critical regulator in Drosophila sensory
organ precursor cell asymmetric divisions. Beyond the recently recognized role in carcino-
genesis, Numb seems to be important in Alzheimer’s disease. This assertion comes from
the involvement in various processes such as synapse morphogenesis, amyloid precursor
protein trafficking, notch signaling, and neurogenesis. The purpose of the present mini-
review is to provide the current picture of Numb’s participation in mechanisms underlying
Alzheimer’s disease pathogenesis and emphasize potential aspects for future research.
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INTRODUCTION
Alzheimer’s disease (AD) is a serious debilitating neurodegen-
erative disorder described by the German psychiatrist and neu-
ropathologist Alois Alzheimer in 1906 during a lecture in Tubin-
gen. It is the most common form of dementia affecting millions of
people worldwide. The major clinical manifestations are memory
loss and cognitive decline. The primary neuropathological fea-
tures of this disorder is neuronal cell death, synaptic loss, amyloid
plaques, and neurofibrillary tangles with a unified theory explain-
ing those findings a major unresolved issue. Amyloid plaques are
extracellular deposits containing Aβ peptide, a proteolytic product
derived from the amyloid precursor protein (APP). Mainly there
are two modes of proteolysis: the sequential action of β and γ sec-
retase which generates the Aβ peptide (amyloidogenic mode) and
the α and γ secretase pathway (non-amyloidogenic mode). Neu-
rofibrillary tangles are aggregates of hyperphosphorylated tau, a
microtubule associated protein (Selkoe, 2001). A very important
milestone in this century of AD research was the identification of
presenilin 1 coding gene PSEN1 as a familiar AD cause (Sherring-
ton et al., 1995). In this study Drosophila numb human homolog
was mapped due to its location 50 kb away from PSEN1. Since
then, there are many indications from the published literature that
Numb may play a role in Alzheimer’s disease pathogenesis and
progression.
NUMB OVERVIEW
Initially numb was described as a cell fate determinant during
sensory organ development in Drosophila embryos. Its name elo-
quently describes the sensory neuron depletion caused by numb
loss of function mutations (Uemura et al., 1989). In humans
there are two homologous genes, NUMB and NUMB-Like. NUMB,
located in 14q23, consists of 13 exons and by alternative splicing
produces at least nine different transcripts (Haider et al., 2011).
The mRNA binding protein Musashi-1 (Kawahara et al., 2008)
and miR146a (Kuang et al., 2009) downregulate Numb protein
levels. Numb does not have any enzymatic activity instead with
its protein interaction domains acts as a molecular scaffold. Adhe-
sion molecules, kinases, endocytic proteins, and ubiquitin ligases
are the Numb’s interacting network partners and reflect its multi-
ple physiological roles (Gulino et al., 2010). Numb associates with
membranes and the subcellular localization is regulated by G-
coupled receptors (Dho et al., 2006) and several kinases among
them aPKC (Smith et al., 2007), Ca2+/calmodulin-dependent
protein kinases (Tokumitsu et al., 2005), AAK1 (Sorensen and
Conner, 2008). At last, conjugation of ubiquitin by LNX (Nie et al.,
2002), Siah-1 (Susini et al., 2001), Mdm2 (Colaluca et al., 2008)
targets Numb for proteasomal degradation.
NUMB ENDOCYTOSIS AND APP TRAFFICKING
Numb is a clathrin-associated sorting protein (CLASP) recogniz-
ing the [FY]XNPX[YF] motif (X any aminoacid; Traub, 2009).
By its DPF and NPF motif (see Figure 1) binds to AP-2 subunit
α-adaptin (Santolini et al., 2000) and EPS15 (Salcini et al., 1997)
accordingly, well known constituents of the endocytic machinery.
It acts not only in the clathrin mediated endocytosis, but also in the
Arf6 pathway and to the endocytic recycling through its interac-
tion with EDH1 and EHD4 proteins (Smith et al., 2004). Different
molecules like: L1 (Nishimura et al., 2003), integrin-b (Nishimura
and Kaibuchi, 2007), E-cadherin (Kuo et al., 2006; Rasin et al.,
2007; Sato et al., 2011) require numb for their endocytosis and
proper membrane targeting.
In AD neurons endocytosis is impaired, with the detection
of enlarged endosomes as an early neuropathological finding
(Cataldo et al., 1997). Interestingly, approximately 70% of the Aβ
peptide secreted to the interstitial fluid is generated by endocytosis
related mechanisms (Cirrito et al., 2008). Because α secretase pre-
dominantly localizes to the cellular membrane whereas β secretase
to acidic intracellular compartments (endosomes), APP’s intra-
cellular trafficking has a principal role in amyloidogenesis (Small
and Gandy, 2006). There is evidence that Numb may serve as a
modulator of APP sorting. Based on FRET and immunoprecipi-
tation experiments, a direct interaction between Numb and APP
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FIGURE 1 | Schematic representation of the four main Numb isoforms and their domain structure. PTB (Phosphotyrosine Binding Domain), NumbF
(Numb family of proteins domain), NPF (asparagine-proline-phenylalanine), DPF (aspartate-proline-phenylalanine).
FIGURE 2 | Numb protein functions relevant to Alzheimer’s disease. (A)
APP subcellular trafficking: p72 and p66 isoforms (exon 6+) promote APP
rooting to lysosomes whereas p71 and p65 (exon 6−) APP amyloidogenic
processing (B) Notch, neurotrophins, and calcium signaling pathways fine
tuning, (C) Cadherin 1 targeting to adherens junctions and subsequently
neurepithelium architecture preservation, (D) Numb interacts directly with
EphB2 and additionally induces Intersectin’s GTP for GDP exchange action on
Cdc42. Cdc42 regulate spine dynamics by local actin remodeling (red lines).
cytoplasmic tail through Numb phosphotyrosine binding domain
(PTB) is established (Roncarati et al., 2002). Numb PTB domain
recognizes the YENTPY conserved motif in APP cytoplasmic tail
(Roncarati et al., 2002). The affinity of these interaction depends
upon the Numb isoform examined and APP intracellular domain
phosphorylation status (Tamayev et al., 2009). According to those
in vitro data the increased Thr668 and Tyr682 phosphorylation in
AD patients makes this interaction weaker (Lee et al., 2003). Also
the p71 isoform (see Figure 1) docks with a greater affinity than the
p72 (Tamayev et al., 2009). Many molecules comprising the APP
intracellular part interactome are PTB domain containing pro-
teins. Characteristic examples are Fe65, JIP, X11α, and β, whose
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role in AD has attracted researchers interest (King and Turner,
2004). Undoubtedly all those factors consist a fine tuned protein
network and alterations could have negative or positive implica-
tions, e.g., X11α slows APP processing reducing Aβ deposition
(King et al., 2003).
NUMB exon 6 alternative splicing give rise to isoforms that dif-
ferentially affect APP processing. Exon 6 encodes a 11 aminoacid
sequence in Numb PTB domain. Human exon 6− isoforms over-
expression increase Aβ production in SH-SY5Y cells bearing the
Swedish double mutation K595N/M596L in APP. On the other
hand exon 6+ isoforms lead to lower Aβ production than Numb
wild type cells. This result is attributed to different subcellular
APP trafficking. Exon 6+ isoforms induce higher APP routing
to lysosomes for degradation whereas exon 6− favor APP recy-
cling (Kyriazis et al., 2008). Additionally Numb-like promote APP
amyloidogenic processing (Schobel et al., 2006). In cortical cell
cultures treated with Aβ, exon 6− isoforms are upregulated (Chig-
urupati et al., 2011). Interestingly, the same study reports increased
Numb exon 6− protein isoforms in triple transgenic AD mouse
model and parietal cortex from affected individuals. An important
open question is the exact numb levels in the hippocampus from
AD patients (an area great interest in AD) due to the elevated
Musashi-1 (rna binding protein downregulating numb mrna)
reported elsewhere (Lovell and Markesbery, 2005). In contrast to
AD, reduced numb levels correlated with cancer development as
shown in breast (Pece et al., 2004) and lung carcinomas (Westhoff
et al., 2009). Whether Numb levels provide a biological explana-
tion of why AD patients have lower incidence of malignancies
than age-matched controls, remains to be clarified (Roe et al.,
2010).
NUMB AND NEUROGENESIS
In adult life nerve cells are continually born in the subgranular
zone of the dentate gyrus and the subventricular zone (Curtis et al.,
2011). Studies in humans and familiar Alzheimer’s disease mouse
models, despite some controversies, demonstrated alterations in
neurogenesis (Lazarov and Marr, 2010). Numb is essential for
the asymmetric divisions during Drosophila embryo peripheral
and central nervous system development. Due to its ability to
interact with dividing cell’s polarity mechanisms, has the poten-
tial to distribute asymmetrically between the two daughter cells
thereby enabling them to choose a different cell fate, acting as a
binary switch (Zhong, 2008). On the contrary, there is an open
discussion about the exact role in cell fate determination during
asymmetric cell divisions in mammals. However, it is evident that
numb plays critical role during mammalian neurogenesis also.
Several Numb/Numbl conditional double knockout mice demon-
strated severe defects in brain development (Petersen et al., 2002,
2004; Li et al., 2003). It is proposed that Numb is crucial for
the neurepithelium architecture maintenance. It associates with
Rab11+ recycling endosomes containing Cadherin 1 and is essen-
tial for the correct membrane targeting of this adherens junction
component (Rasin et al., 2007). Postnatal Numb/numbl deletion
seriously compromises ependymal wall integrity and subventric-
ular zone homeostasis (Kuo et al., 2006). Despite the recent data
indicating that SVZ neurogenesis largely stops after 18 months of
age (Sanai et al., 2011) there are reports that stroke (Marti-Fabregas
et al., 2010) and Huntington disease induce a substantial upregula-
tion (Curtis et al., 2003). Furthermore, numb modulates signaling
pathways such as Hedgehog (Marcotullio et al., 2006) and Notch
with well recognized role in adult neurogenesis (Lai et al., 2003;
Imayoshi et al., 2010).
NUMB AND SYNAPSE MORPHOGENESIS
A very interesting observation in AD is the dramatic reduction in
dendritic spines and its good correlation with disease progression
(Terry et al., 1991). Cortical rewiring through new synapse forma-
tion is a key mechanism for memory and cognition (McAllister,
2007). Numb affects synapse formation through several mecha-
nisms. In particular, Numb p72 isoform overexpression in cultured
hippocampal neurons leads to an increase in spine length. In the
case of aminoacid 1–183 and 184–592 fragment overexpression, an
additional decrease in spine density and percentage of protrusions
with a spine head is observed. Numb interacts with intersectin
[possesses a guanine nucleotide exchange factor (GEF) activity
for Cdc42], Rac GEF Tiam1, and dual Rho GEF Kalirin. Cdc42,
Rac, and Rho are members of the Rho family GTPases (Nishimura
et al., 2006). They regulate actin dynamics and have a pivotal role in
synapse formation as reflected from the mental retardation syn-
dromes linked to genes participating in this signaling pathway
(Ramakers, 2002). GEFs activate Rho proteins by a GTP for GDP
exchange. In the case of intersectin we have to mention that is
a chromosome 21 encoded protein with a direct involvement in
Down syndrome (Chang and Min, 2009). At last, Numb interact
with NMDA glutamate receptors and EphB2 (Nishimura et al.,
2006). EphB2 is essential for the synapse to function properly (Lai
and Ip, 2009) and is downregulated in AD brains (Cisse et al.,
2011).
NUMB AND SIGNALING PATHWAYS
Much work has focused on the regulation of intracellular signal-
ing cascades by Numb. First of all, Numb is the classical Notch
pathway inhibitor. Mammals have four different Notch receptors
mediating cell–cell communication (Brou, 2009). In adult nervous
system, Notch signaling has linked with various functions from
long term potentiation (Wang et al., 2004), to dendrite arboriza-
tion (Berezovska et al., 1999) and neurogenesis (Breunig et al.,
2007; Imayoshi et al., 2010). The p66 isoform was shown to pro-
mote Notch 1 ubiquitination by recruiting E3 ubiquitin ligase Itch
(McGill and McGlade, 2003; McGill et al., 2009). The ability to
exert a repressive effect on Notch signaling differs between Numb
isoforms (Beres et al., 2011). It is proposed that AICD (APP’s C
terminal part generated from γ cleavage) binds Numb and inhibits
Notch (Roncarati et al., 2002). In the case of Notch 1 and 2 recep-
tors, a direct interaction with APP was observed (Chen et al., 2006).
Interestingly, Notch 1 immunoreactivity in the hippocampus of
AD patients was increased (Berezovska et al., 1998). Similarly to
APP, Notch receptors are α and γ secretase substrates with this
proteolytic events being prerequisite for signal transduction. This
is why, in the field of AD therapeutics, the main obstacle toward
a safe γ secretase inhibitor is the compromised Notch signaling
related toxicities (Oehlrich et al., 2011).
Beyond Notch, Numb seems to play a role in neurotrophin
signaling. This pathway promotes neuronal survival (Heumann,
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1994) and is perturbed in AD brains (Williams et al., 2006). Espe-
cially the TrkA and TrkB receptors are downregulated (Ginsberg
et al., 2006). Recently a study demonstrated that Numb required
for TrkB endocytosis and migration of cerebellum granule cells
across BDNF gradient (Zhou et al., 2011). PC12 cell overexpress-
ing exon 6− isoforms display increased NGF induced neurite
outgrowth partly due to increased TrkA levels (Pedersen et al.,
2002). This outgrowth is a well recognized phenomenon which
makes PC12 cells a popular neuronal model. Furthermore TrkA
and TrkB endocytosis in sympathetic and hippocampal neurons
requires EHD4 (Pincher), a Numb binding partner (Valdez et al.,
2005).
Several lines of evidence point toward a contribution to the
calcium mishandling observed in AD (Supnet and Bezprozvanny,
2010). Exon 6− isoforms overexpression in PC12 cells induce
neurite outgrowth without requiring NGF treatment in a way
depending upon voltage-gated calcium channels (Lu et al., 2009).
Additionally these cells are more vulnerable to Aβ toxicity due to
a calcium related mechanism (Chan et al., 2002) and after trophic
factor withdrawal from the culture medium TRPV6 is upregulated
leading to calcium dysregulation and increased cell death (Kyriazis
et al., 2010).
Recently, an interesting finding was that Numb interacts
with the cell cycle regulatory protein Polo-like kinase 1 (Plk1;
Schmit et al., 2012). Plk1 activity is elevated in AD patients and
PLK1 silencing reduces Aβ-induced neuronal cell death (Song
et al., 2011). Indeed, a link between cell cycle disturbances and
neuronal death has now been established in AD. It is proposed
that inappropriate reentry into a mitotic cell cycle triggers neu-
ronal cell death (Herrup, 2012). In this context, cyclin-dependent
kinase 5, which prevent this reentry (Zhang et al., 2010) regu-
lates collapsin response mediator protein-2 (CRMP-2). Of note,
CRMP-2 has a role in Numb-mediated endocytosis (Nishimura
et al., 2003), is phosphorylated early in AD (Cole et al., 2007)
and is a substrate for glycogen synthase kinase 3 (Gsk3β; Cole
et al., 2004), a known molecular player in AD (Kremer et al.,
2011).
CONCLUSION
There is already ample in vitro evidence that this protein affect neu-
rodegeneration in multiple ways. In vivo, Numb exon 6− isoforms
has been shown to increase in both triple transgenic AD mouse
model and affected human individuals. In the future the develop-
ment of mice bearing a known AD causing mutation with targeted
disruption of specific Numb isoforms will provide a unique angle
to approach the study of Numb’s role in AD. To what extent AD
pathogenic pathways are Numb-dependent in vivo is not yet clear
but considering the data provided so far there are many excit-
ing findings to come in the next years. The clinical significance
of this molecule as a potential drug target or biomarker remains
to be convincingly demonstrated by future studies. The fact that
Numb has a tumor suppressor activity, makes problematic target
for future drug research. However elucidating further the physio-
logical relevance of this Numb APP interaction could provide us
with a more complete understanding of the mechanisms involved
in this devastating illness.
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